Global Lateral Epicondylitis (Tennis Elbow) Market to Reach Worth USD 10,582.1 Mn by 2022: Credence Research
New Market Research Reports Titled "Global Lateral Epicondylitis (Tennis Elbow) Market to Reach Worth USD 10,582.1 Mn by 2022: Credence Research" Has Been Added to Credenceresearch.com Report Database.
San Jose, CA, June 17, 2016 --(PR.com)-- According to the latest report published by Credence Research, Inc. “Lateral Epicondylitis (Tennis Elbow): Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the Lateral Epicondylitis (Tennis Elbow) market was valued at USD 8,104.0 Mn in 2015, and is expected to reach USD 10,582.1 Mn by 2022, expanding at a CAGR of 3.2% from 2016 to 2022.
Browse the full report Lateral Epicondylitis (Tennis Elbow): Market Growth, Future Prospects and Competitive Analysis, 2016-2022 report at http://www.credenceresearch.com/report/lateral-epicondylitis-tennis-elbow-market
Market Insights
Growth in healthcare investments, prevalence of lateral epicondylitis and growing high-risk geriatric population are the major factors driving the global market growth for lateral epicondylitis treatment. North America is the largest regional market at a market share of over 35% in 2015, and the dominance of this region is anticipated to continue through 2022. Rising incidence of sports injuries and high awareness about treatment and management of tennis elbow together drive the North America lateral epicondylitis market.
Browse All Reports of This Category @ http://www.credenceresearch.com/industry/biotechnology-market
Among the treatment types, corticosteroids injections segment is the most prominent market in terms of revenue. However, non-surgical therapies such as platelet rich plasma (PRP), splint elbow brace, ice packs and others will take approximately 40% market share in 2015. It is reported that around 95% of the total tennis elbow patients get relief from these therapies and do not need to opt for other medications and or surgical procedures. PRP is presently being investigated as it can act as an effective treatment that can heal a variety of tendon injuries. It possess a high concentration of proteins referred to as growth factors that can play a significant role in the healing of injuries. Prevailing research on lateral epicondylitis and PRP is very promising. A few treatment centers across the globe are integrating PRP injections into the nonsurgical treatment regime for tendon elbow. Further long-term results will add on to footprint of this segment in the tennis elbow market.
Surgical treatments such as arthroscopy and open surgeries are opted as a final remedial measure for treating tennis elbow. Technological advancements in the nature of surgical equipment and guidance systems will support the demand for these treatment methods. Furthermore growing preference for minimally invasive procedures due to advantages such as quicker recuperation, better safety outcomes and less blood loss and risk of infection are the major factors that urge the demand for arthroscopy for tennis elbow treatment.
Blog URL - http://www.mobilecomputingtoday.co.uk/3696/global-lateral-epicondylitis-tennis-elbow-market-reach-worth-usd-10582-1-2022-rising-prevalence-condition-determine-market-growth-credence-research/
About Credence Research:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
For More Information, Visit: http://www.credenceresearch.com/
Media Contact
Company Name: Credence Research
Contact Person: Chris Smith,
Designation: Global Sales Manager
Phone: 1-800-361-8290
Address: 105 N 1st ST #429, San Jose, CA 95103
E-mail: sales@credenceresearch.com
Browse the full report Lateral Epicondylitis (Tennis Elbow): Market Growth, Future Prospects and Competitive Analysis, 2016-2022 report at http://www.credenceresearch.com/report/lateral-epicondylitis-tennis-elbow-market
Market Insights
Growth in healthcare investments, prevalence of lateral epicondylitis and growing high-risk geriatric population are the major factors driving the global market growth for lateral epicondylitis treatment. North America is the largest regional market at a market share of over 35% in 2015, and the dominance of this region is anticipated to continue through 2022. Rising incidence of sports injuries and high awareness about treatment and management of tennis elbow together drive the North America lateral epicondylitis market.
Browse All Reports of This Category @ http://www.credenceresearch.com/industry/biotechnology-market
Among the treatment types, corticosteroids injections segment is the most prominent market in terms of revenue. However, non-surgical therapies such as platelet rich plasma (PRP), splint elbow brace, ice packs and others will take approximately 40% market share in 2015. It is reported that around 95% of the total tennis elbow patients get relief from these therapies and do not need to opt for other medications and or surgical procedures. PRP is presently being investigated as it can act as an effective treatment that can heal a variety of tendon injuries. It possess a high concentration of proteins referred to as growth factors that can play a significant role in the healing of injuries. Prevailing research on lateral epicondylitis and PRP is very promising. A few treatment centers across the globe are integrating PRP injections into the nonsurgical treatment regime for tendon elbow. Further long-term results will add on to footprint of this segment in the tennis elbow market.
Surgical treatments such as arthroscopy and open surgeries are opted as a final remedial measure for treating tennis elbow. Technological advancements in the nature of surgical equipment and guidance systems will support the demand for these treatment methods. Furthermore growing preference for minimally invasive procedures due to advantages such as quicker recuperation, better safety outcomes and less blood loss and risk of infection are the major factors that urge the demand for arthroscopy for tennis elbow treatment.
Blog URL - http://www.mobilecomputingtoday.co.uk/3696/global-lateral-epicondylitis-tennis-elbow-market-reach-worth-usd-10582-1-2022-rising-prevalence-condition-determine-market-growth-credence-research/
About Credence Research:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
For More Information, Visit: http://www.credenceresearch.com/
Media Contact
Company Name: Credence Research
Contact Person: Chris Smith,
Designation: Global Sales Manager
Phone: 1-800-361-8290
Address: 105 N 1st ST #429, San Jose, CA 95103
E-mail: sales@credenceresearch.com
Contact
Credence Research
Chris Smith
1-800-361-8290
http://www.credenceresearch.com/
105 N 1st ST #429, San Jose, CA 95103
Chris Smith
1-800-361-8290
http://www.credenceresearch.com/
105 N 1st ST #429, San Jose, CA 95103
Contact
Categories